Sign in

CIK 0001521036

  • Large accelerated filer

Lantheus Holdings, Inc.

Sign in to watch
Ticker
LNTH
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
352318913
Phone
+1 978-671-8001
Business address
201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
Former names
Lantheus MI Holdings, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-05 Morgan Amanda Michelle Chief Commercial Officer Grant or award +26,208 64,748
2026-03-05 Morgan Amanda Michelle Chief Commercial Officer Shares withheld for taxes −595 $76.31 $45K 64,153
2026-03-02 Morgan Amanda Michelle Chief Commercial Officer Grant or award +2,782 41,876
2026-03-02 Morgan Amanda Michelle Chief Commercial Officer Shares withheld for taxes −3,336 $76.30 $255K 38,540
2025-12-15 Morgan Amanda Michelle Chief Commercial Officer Shares withheld for taxes −368 $66.57 $24K 39,094
2025-03-05 Morgan Amanda Michelle Chief Commercial Officer Grant or award +14,928 39,580
2025-03-05 Morgan Amanda Michelle Chief Commercial Officer Grant or award · Stock Option (right to buy) +8,704 8,704
2025-03-03 Morgan Amanda Michelle Chief Commercial Officer Shares withheld for taxes −759 $94.86 $72K 24,652
2024-12-15 Morgan Amanda Michelle Chief Commercial Officer Shares withheld for taxes −356 $93.48 $33K 25,055

Page 1 of 1 · 9 trades